Art

J-GLOBAL ID：200902283203454507   Reference number：05A0482883

Type III Hyperlipoproteinemia Exaggerated by Sheehan’s Syndrome With Advanced Systemic Atherosclerosis A 28-Year Clinical Course

III型高リポ蛋白質血症は進行性全身性アテローム性動脈硬化症を伴うSheehan症候群によって強められる 28年間の臨床経過

Author (11)： KAWASHIRI Masa-aki (Molecular Genetics of Cardiovascular Disorders, Div. of Cardiovascular Disease) ,  HIGASHIKATA Toshinori (Molecular Genetics of Cardiovascular Disorders, Div. of Cardiovascular Disease) ,  TAKATA Mutsuko (Molecular Genetics of Cardiovascular Disorders, Div. of Cardiovascular Disease) ,  KATSUDA Shoji (Molecular Genetics of Cardiovascular Disorders, Div. of Cardiovascular Disease) ,  MIWA Kenji (Molecular Genetics of Cardiovascular Disorders, Div. of Cardiovascular Disease) ,  NOHARA Atsushi (Dep. of General Medicine, Kanazawa Univ. Hospital) ,  INAZU Akihiro (School of Health Sci., Fac. of Medicine) ,  KOBAYASHI Junji (Dep. for Life-style-related Diseases, Graduate School of Medical Sci.s, Kanazawa Univ.) ,  SHIMIZU Masami (Molecular Genetics of Cardiovascular Disorders, Div. of Cardiovascular Disease) ,  KOIZUMI Junji (Dep. of General Medicine, Kanazawa Univ. Hospital) ,  MABUCHI Hiroshi (Molecular Genetics of Cardiovascular Disorders, Div. of Cardiovascular Disease)
Material： Circulation Journal  (Circ J)
Volume： 69  Issue： 6  Page： 746-751 (J-STAGE)  Publication year： 2005 
JST Material Number： F0908A  ISSN： 1346-9843  Document type： Article
Article type： 短報  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *hyperlipoproteinemia ,...
Semi thesaurus term： Sheehan syndrome

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=05A0482883&from=J-GLOBAL&jstjournalNo=F0908A") }}

JST classification (1)： Metabolic diseases,nutritional diseases in general.  (GD05010J)

Substance index (1)： Cholesterol

Reference (22)：

• 1. Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic disease: New perspectives based on the Framingham study. Ann Intern Med 1979; 90: 85-91.
• 2. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D. Serum cholesterol, blood pressure, and mortality: Implications from a cohort of 361,662 men. Lancet 1986; 2: 933-926.
• 3. Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience): Prospective Cardiovascular Munster study. Am J Cardiol 1992; 70: 733-737.
• 4. Mahley RW, Rall SC Jr. Type III hyperlipoproteinemia (dysbetalipoproteinemia): The role of apolipoprotein E in normal and abnormal lipoprotein metabolilsm. <i>In:</i> Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic & molecular bases of inherited disease, 8^th edn. New York: McGraw-Hill; 2001; 2835-2862.
• 5. Schneider WJ, Kovanen PT, Brown MS, Goldstein JL, Utermann G, Weber W, et al. Familial dysbetalipoproteinemia: Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows. J Clin Invest 1981; 68: 1075-1085.

Terms in the title (4)： III型高リポ蛋白質血症 ,  全身性アテローム性動脈硬化症 ,  Sheehan症候群 ,  臨床経過